Yoichi Negishi Selected Research

aspartyl- phenylalanyl- lysyl- leucyl- phenylalanyl- alanyl- valyl- tyrosyl- isoleucyl- lysyl- tyrosyl- arginine

5/2012

Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoichi Negishi Research Topics

Disease

21	Neoplasms (Cancer) 10/2019 - 04/2006
6	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022 - 03/2014
3	Communicable Diseases (Infectious Diseases) 12/2021 - 01/2016
3	Muscular Dystrophies (Muscular Dystrophy) 10/2021 - 01/2012
3	Ischemia 01/2018 - 06/2012
2	Pneumococcal Infections 04/2021 - 08/2018
2	Myotonic Dystrophy (Dystrophia Myotonica) 01/2018 - 01/2013
2	Myotonia 01/2018 - 01/2013
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2018 - 03/2014
1	Wasting Syndrome (Wasting Disease) 01/2022
1	Neuroblastoma 07/2021
1	Asthma (Bronchial Asthma) 05/2021
1	Infections 04/2021
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Shock 03/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Hyperthermia 01/2013
1	Hepatocellular Carcinoma (Hepatoma) 12/2012
1	Carcinogenesis 01/2012
1	Mucositis 05/2011
1	Ovarian Neoplasms (Ovarian Cancer) 05/2011
1	Kaposi Sarcoma (Kaposi's Sarcoma) 05/2011
1	Arthritis (Polyarthritis) 11/2010
1	Ascites 01/2008
1	Osteoporosis 07/2006
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2006
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2006
1	Embryonal Carcinoma 08/2004
1	Lung Diseases (Lung Disease) 08/2002

Drug/Important Bio-Agent (IBA)

21	Liposomes (Liposome)IBA 10/2021 - 04/2006
10	Peptides (Polypeptides)IBA 10/2021 - 02/2010
4	AntigensIBA 12/2021 - 01/2018
4	VaccinesIBA 12/2021 - 08/2018
4	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2013
4	Pharmaceutical PreparationsIBA 10/2019 - 05/2012
4	Syndecan-2IBA 05/2011 - 01/2010
3	Laminin (Merosin)IBA 10/2019 - 08/2010
3	LigandsIBA 05/2011 - 02/2010
2	DystrophinIBA 01/2022 - 01/2018
2	Contrast MediaIBA 10/2019 - 07/2013
2	Chloride Channels (Chloride Channel)IBA 01/2018 - 01/2013
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2014
2	MorpholinosIBA 01/2018 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2013 - 05/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 01/2008
2	SyndecansIBA 05/2011 - 02/2010
2	LipidsIBA 01/2008 - 08/2002
1	Dystroglycans (Dystroglycan)IBA 10/2021
1	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 07/2021
1	Messenger RNA (mRNA)IBA 05/2021
1	PeroxiredoxinsIBA 05/2021
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2021
1	caffeic acidIBA 04/2021
1	PolyphenolsIBA 01/2021
1	1,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA 08/2018
1	pneumococcal surface protein AIBA 08/2018
1	3- (N- (N',N'- dimethylaminoethane)carbamoyl)cholesterolIBA 08/2018
1	Diphtheria ToxinIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	MyostatinIBA 02/2015
1	Biocompatible Materials (Biomaterials)IBA 07/2013
1	contrast agent BR1IBA 12/2012
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2012
1	SolutionsIBA 06/2012
1	IntegrinsIBA 05/2012
1	aspartyl- phenylalanyl- lysyl- leucyl- phenylalanyl- alanyl- valyl- tyrosyl- isoleucyl- lysyl- tyrosyl- arginineIBA 05/2012
1	Nucleic AcidsIBA 01/2012
1	ChemokinesIBA 01/2012
1	liposomal doxorubicin (Doxil)FDA Link 05/2011
1	CytokinesIBA 11/2010
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2010
1	Interleukin-12 (IL 12)IBA 03/2010
1	laminin AIBA 02/2010
1	LuciferasesIBA 01/2008
1	Biological ProductsIBA 07/2006
1	Vitamin D FDA LinkGeneric 07/2006
1	Folic Acid (Vitamin M)FDA LinkGeneric 04/2006
1	stearylamineIBA 04/2006
1	poly(ethylene glycol)-folateIBA 04/2006
1	Insulin-Like Growth Factor I (IGF-1)IBA 08/2004
1	Insulin (Novolin)FDA Link 08/2004

Therapy/Procedure

12	Therapeutics 01/2018 - 01/2010
1	Drug Therapy (Chemotherapy) 10/2019
1	Intravenous Injections 01/2018
1	Immunotherapy 01/2013
1	Microbubbles 12/2012